Literature DB >> 4126737

The frequency of relapse in multiple sclerosis. A study based on 245 cases.

F Lhermitte, R Marteau, J Gazengel, G Dordain, G Deloche.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4126737     DOI: 10.1007/bf00315959

Source DB:  PubMed          Journal:  Z Neurol        ISSN: 0012-1037


× No keyword cloud information.
  10 in total

1.  THE BENIGN FORM OF MULTIPLE SCLEROSIS: RESULTS OF A LONG-TERM STUDY.

Authors:  D MCALPINE
Journal:  Br Med J       Date:  1964-10-24

2.  CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL. 3. CLINICAL COURSE AND PROGNOSIS RELATED TO AGE AT ONSET.

Authors:  U LEIBOWITZ; M ALTER; L HALPERN
Journal:  Neurology       Date:  1964-10       Impact factor: 9.910

3.  CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL.I. A CLINICAL ANALYSIS BASED ON A COUNTRY-WIDE SURVEY.

Authors:  U LEIBOWITZ; L HALPERN; M ALTER
Journal:  Arch Neurol       Date:  1964-05

4.  Pregnancy as a factor influencing relapse in disseminated sclerosis.

Authors:  J H MILLAR; R S ALLISON; E A CHEESEMAN; J D MERRETT
Journal:  Brain       Date:  1959-09       Impact factor: 13.501

5.  Long-term treatment of multiple sclerosis with corticotrophin.

Authors:  J H Millar; C J Vas; M J Noronha; L A Liversedge; M D Rawson
Journal:  Lancet       Date:  1967-08-26       Impact factor: 79.321

6.  The course of multiple sclerosis in 73 cases with computer-designed curves.

Authors:  T Fog; F Linnemann
Journal:  Acta Neurol Scand Suppl       Date:  1970

7.  Studies on natural history of multiple sclerosis. 4. Clinical features of the onset bout.

Authors:  J F Kurtzke; G W Beebe; B Nagler; T L Auth; L T Kurland; M D Nefzger
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

8.  Multiple sclerosis in Rochester, Minn. A 60-year appraisal.

Authors:  A K Percy; F T Nobrega; H Okazaki; E Glattre; L T Kurland
Journal:  Arch Neurol       Date:  1971-08

9.  [The mild forms of multiple sclerosis].

Authors:  M Bonduelle
Journal:  Presse Med       Date:  1967-10-07       Impact factor: 1.228

10.  Therapeutic trial of Imuran (azathioprine) in multiple sclerosis.

Authors:  W S Cendrowski
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

  10 in total
  2 in total

1.  Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.

Authors:  U Patzold; P Pocklington
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

Review 2.  Predicting responders to therapies for multiple sclerosis.

Authors:  Jordi Río; Manuel Comabella; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2009-10       Impact factor: 42.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.